Literature DB >> 2868774

Torsade de pointes after astemizole overdose.

T M Craft.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868774      PMCID: PMC1339646          DOI: 10.1136/bmj.292.6521.660

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  2 in total

1.  Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations.

Authors:  R Krapf; M Gertsch
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

2.  Cardiac histamine receptors: differences between left and right atria and right ventricle.

Authors:  S C Verma; J H McNeill
Journal:  J Pharmacol Exp Ther       Date:  1977-02       Impact factor: 4.030

  2 in total
  28 in total

Review 1.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

2.  Torsades de pointes tachycardia induced by common cold compound medication containing chlorpheniramine.

Authors:  Amir M Nia; Uwe Fuhr; Natig Gassanov; Erland Erdmann; Fikret Er
Journal:  Eur J Clin Pharmacol       Date:  2010-07-31       Impact factor: 2.953

3.  Torsades de pointes complicating treatment with terfenadine.

Authors:  T J MacConnell; A J Stanners
Journal:  BMJ       Date:  1991-06-15

4.  Second-generation antihistamines: a comparative review.

Authors:  J W Slater; A D Zechnich; D G Haxby
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 5.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

6.  Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.

Authors:  F J de Abajo; L A Rodríguez
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

Review 7.  Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

Review 8.  Optimum pharmacological management of chronic rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

9.  Block of HERG k channel by classic histamine h(1) receptor antagonist chlorpheniramine.

Authors:  Hee-Kyung Hong; Su-Hyun Jo
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

10.  Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast.

Authors:  Hanna Phan; Matthew L Moeller; Milap C Nahata
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.